Skip to Content

Invacare anticipates strong sequential growth in Q4

Invacare anticipates strong sequential growth in Q4

ELYRIA, Ohio – Invacare anticipates sequential growth in the fourth quarter of 2022, due to strong demand for its lifestyle and mobility & seating products and elevated open orders. Based on preliminary unaudited fourth quarter results, the company anticipates reporting the following results as compared to third quarter 2022: Net sales growth of 6% to $181 million as compared to $170 million, with growth in all regions and in all major product categories; gross margins, excluding the respiratory charges in 3Q22, improved substantially by 310 basis points to 26.6%; net loss and adjusted EBITDA significantly improved, driven by revenue growth, gross margin expansion due to pricing actions, favorable product mix and lower freight costs, and lower SG&A expense; and, Europe returned to profitability, confirming the 3Q22 operating loss for the segment was out of the ordinary. Invacare filed for Chapter 11 bankruptcy protection this week.

Comments

To comment on this post, please log in to your account or set up an account now.